The Role of IL-6 and TMEM100 in Lumbar Discogenic Pain and the Mechanism of the Glycine-Serine-Threonine Metabolic Axis: A Metabolomic and Molecular Biology Study
Zhaoyang Guo,Yuanye Ma,Yaqing Wang,Hongfei Xiang,Shang-You Yang,Zhu Guo,Ronghuan Wang,Wujun Chen,Dongming Xing,Bohua Chen,Hao Tao,Xiaolin Wu
DOI: https://doi.org/10.2147/JPR.S400871
IF: 2.8319
2023-02-16
Journal of Pain Research
Abstract:Zhaoyang Guo, 1, &ast Yuanye Ma, 1, &ast Yaqing Wang, 2 Hongfei Xiang, 1 Shang-You Yang, 3 Zhu Guo, 1 Ronghuan Wang, 1 Wujun Chen, 4 Dongming Xing, 4, 5 Bohua Chen, 1 Hao Tao, 1 Xiaolin Wu 1, 4 1 Department of Orthopedics, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; 2 Department of Nephrology, The First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China; 3 School of Medicine-Wichita, University of Kansas, Wichita, KS, USA; 4 Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, People's Republic of China; 5 School of Life Sciences, Tsinghua University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaolin Wu; Hao Tao, Department of Orthopedics, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China, Email ; Background: It is well established that discogenic low back pain (DLBP) is often caused by the inflammatory response during intervertebral disc degeneration (IDD). However, it remains unclear how inflammatory mediators such as Interleukin-6 (IL-6) are involved in discogenic pain caused by degeneration and intervertebral disc (IVD) metabolism. The purpose of this study is to study the relationship between IL-6 and Transmembrane protein 100 (TMEM100), and to analyze the different metabolites and metabolic pathways in various rat intervertebral discs by metabonomics. Methods: We established a rat model of IDD-DLBP by disc punctures and PBS infusion to examine the rat pain behaviors. Intervertebral disc tissues were harvested for molecular biology experiments to explore the relationship between IL-6 and TMEM100. High-resolution mass spectrometry (HRMS) was performed for untargeted metabolomics, and nuclear magnetic resonance spectroscopy metabolomics (MRS) for differential metabolites and metabolic pathways. Results: The results showed a significant decrease in vonFrey test, hot plate test and acetone test (P < 0.05). The expression of IL-6 and TMEM100 in DLBP model was significantly higher than that in sham control group and IDD discs without PBS infusion group (P < 0.05). There were 15 major contributing metabolites identified in the DLBP intervertebral discs through metabolomic studies, involving 6 major metabolic pathways. The main differential metabolites included nitric oxide (NO), ammonia, and lactic acid as the metabolic endpoints; and the differential metabolic pathways included the glycine-serine-threonine (Gly-Ser-Thr), which is gradually weakened with the progression of inflammation. Conclusion: The change of TMEM100 expression mediated by il-6 is related to the Gly-Ser-Thr metabolic axis and plays an important role in the relief of discogenic pain. Keywords: metabolomics, DLBP, IDD, IL-6, TMEM100, inflammatory mediators Discogenic low back pain (DLBP) is a chronic intractable pain caused by intradiscal rupture. 1 Current evidence suggests that more than 600 million people worldwide will suffer from DLBP at some time in their lives, and the treatment of low back pain has become a significant economic burden for this patient population. 2 Various factors have been established to cause DLBP, among which intervertebral disc degeneration (IDD) is one of the common causes of low back pain. 3 It has been reported that up to 42% of low back pain is related to intervertebral disc disease. 4 It is well established that the causes of DLBP are endplate injury, radial rupture of inner annulus fibrosus, degradation of intervertebral disc matrix, inflammatory reaction of intervertebral disc stroma, and persistent production of inflammatory mediators during pain. 5 IDD is caused by chemical stimulation of nerve endings of the outer annulus fibrosus. IL-6 is an important inflammatory mediator that participates in immune and inflammatory responses. An ample body of evidence suggests that IL-6 is highly expressed in degenerative intervertebral discs and adjacent dorsal root ganglion (DRG). 6 TMEM 100 is a pain signal modulator expressed in DRG discovered in recent years that mainly localized to calcitonin gene-related peptide (CGRP)-positive peptide neurons in DRG and trigeminal ganglia, and its expression is reportedly increased in inflammatory pain. 7,8 Little is currently known about the relationship between IL-6 and TMEM100, nor is the relationship and expression of the two in discogenic pain caused b -Abstract Truncated-
clinical neurology